Iatrogenic harm in functional neurological disorder.

IF 10.6 1区 医学 Q1 CLINICAL NEUROLOGY Brain Pub Date : 2024-09-06 DOI:10.1093/brain/awae283
Caoimhe Mcloughlin, Wei Hao Lee, Alan Carson, Jon Stone
{"title":"Iatrogenic harm in functional neurological disorder.","authors":"Caoimhe Mcloughlin, Wei Hao Lee, Alan Carson, Jon Stone","doi":"10.1093/brain/awae283","DOIUrl":null,"url":null,"abstract":"<p><p>Functional Neurological Disorder (FND) is continuing to gain increasing recognition globally as a valid and potentially treatable disorder. Iatrogenic harm towards patients with FND is significant however, and has been around for centuries. Despite advances in our understanding around the aetiology, pathophysiology, and treatment of FND, many aspects of such harm continue to persist. Avoidance of iatrogenic harm has been highlighted by clinicians as one of the most important therapeutic considerations in FND, however, the sources and range of potential harms, or indeed ways to mitigate them, have not been previously summarised. Using a combination of clinical and research experience and scoping review methodology, this review aims to describe the main sources of iatrogenic harm towards patients with FND, including harm from misdiagnosis, delayed diagnosis and treatment, direct harm from professional interactions, other stigma-related harms, harm related to diagnostic overshadowing and over-diagnosis of FND. We also describe some potential ways to address and prevent such harms, such as ways to reduce misdiagnosis with a focus on rule in signs, optimising teaching and communication, ensuring parity of FND with other medical conditions, and continued integration of patient and professional organisations.</p>","PeriodicalId":9063,"journal":{"name":"Brain","volume":null,"pages":null},"PeriodicalIF":10.6000,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Brain","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/brain/awae283","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Functional Neurological Disorder (FND) is continuing to gain increasing recognition globally as a valid and potentially treatable disorder. Iatrogenic harm towards patients with FND is significant however, and has been around for centuries. Despite advances in our understanding around the aetiology, pathophysiology, and treatment of FND, many aspects of such harm continue to persist. Avoidance of iatrogenic harm has been highlighted by clinicians as one of the most important therapeutic considerations in FND, however, the sources and range of potential harms, or indeed ways to mitigate them, have not been previously summarised. Using a combination of clinical and research experience and scoping review methodology, this review aims to describe the main sources of iatrogenic harm towards patients with FND, including harm from misdiagnosis, delayed diagnosis and treatment, direct harm from professional interactions, other stigma-related harms, harm related to diagnostic overshadowing and over-diagnosis of FND. We also describe some potential ways to address and prevent such harms, such as ways to reduce misdiagnosis with a focus on rule in signs, optimising teaching and communication, ensuring parity of FND with other medical conditions, and continued integration of patient and professional organisations.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
功能性神经紊乱的先天性伤害。
功能性神经失调症(FND)作为一种有效且可治疗的疾病,正在不断获得全球越来越多的认可。然而,对 FND 患者造成的先天性伤害是巨大的,而且已经存在了几个世纪。尽管我们对 FND 的病因、病理生理学和治疗方法的认识不断进步,但这种伤害的许多方面依然存在。临床医生一直强调,避免先天性伤害是 FND 治疗中最重要的考虑因素之一,但是,以前并没有总结过潜在伤害的来源和范围,或者减轻伤害的方法。本综述结合临床和研究经验以及范围界定综述方法,旨在描述对 FND 患者造成的先天性伤害的主要来源,包括误诊、延误诊断和治疗造成的伤害、专业人员互动造成的直接伤害、其他与污名化相关的伤害、与 FND 诊断阴影和过度诊断相关的伤害。我们还介绍了一些解决和预防此类伤害的潜在方法,例如减少误诊的方法,重点是体征规则、优化教学和沟通、确保FND与其他病症的同等地位,以及继续整合患者和专业组织。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Brain
Brain 医学-临床神经学
CiteScore
20.30
自引率
4.10%
发文量
458
审稿时长
3-6 weeks
期刊介绍: Brain, a journal focused on clinical neurology and translational neuroscience, has been publishing landmark papers since 1878. The journal aims to expand its scope by including studies that shed light on disease mechanisms and conducting innovative clinical trials for brain disorders. With a wide range of topics covered, the Editorial Board represents the international readership and diverse coverage of the journal. Accepted articles are promptly posted online, typically within a few weeks of acceptance. As of 2022, Brain holds an impressive impact factor of 14.5, according to the Journal Citation Reports.
期刊最新文献
Phase 2b program with sonlicromanol in patients with mitochondrial disease due to m.3243A>G mutation. Focal brain administration of antiseizure medications improves outcomes and reduces side effects. Tau, synapse loss and gliosis progress in an Alzheimer's mouse model after amyloid-β immunotherapy. Mental health disorders before, during and after the COVID-19 pandemic: a nationwide study. Smaller cingulate grey matter mediates the association between dual-task gait and incident dementia.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1